SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?

Molecular Endocrinology

Volumn 20, Issue 2, 2006, Pages 426-436

  Ruan, Weifeng ^a   Fahlbusch, Fabian ^a   Clemmons, David R ^b   Monaco, Marie E ^a   Walden, Paul D ^a   Silva, Antonio P ^c   Schmid, Herbert A ^c   Kleinberg, David L ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; OCTREOTIDE; PASIREOTIDE; PLACEBO; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL DIVISION; CONTROLLED STUDY; FEMALE; HYPOPHYSECTOMY; HYPOPHYSIS; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PUBERTY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; CELL DIVISION; FEMALE; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; MAMMARY GLANDS, ANIMAL; OCTREOTIDE; PHOSPHORYLATION; RATS; RATS, INBRED STRAINS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

ANIMALIA;

EID: 31444447551     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0283     Document Type: Article

References (42)

1. Melmed S, Kleinberg D 2003 Anterior pituitary. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams textbook of endocrinology. Philadelphia: Saunders; 177-279
2. Newman CB, Melmed S, Snyder PJ, Young WF, Boyajay LD, Levy R, Stewart WN, Klibanski A, Molitch ME, Gagel RF, Boyd AE, Sheeler L, Cook D, Malarkey WB, Jackson IMD, Vance ML, Thorner MO, Ho PJ, Jaffe CA, Frohman LA, Kleinberg DL 1995 Safety and efficacy of long term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients - a clinical research center study. J Clin Endocrinol Metab 80:2768-2775
3. Weckbecker G, Briner U, Lewis I, Bruns C 2002 SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs. Endocrinology 143:4123-4130
4. Murray RD, Kim K, Ren SG, Chelly M, Umehara Y, Melmed S 2004 Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis. J Clin Invest 114:349-356
5. Ruan W, Newman CB, Kleinberg DL 1992 Intact and aminoterminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci USA 89:10872-10876
6. Ruan W, Kleinberg DL 1999 Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140:5075-5081
7. Yee D, Chavez JB, Ruan WF, Kleinberg DL, Inhibition of normal mammary gland development and breast cancer growth by IGFBP1. Proc American Society of Clinical Oncology, 2000, 19: 209A (Abstract A13)
8. Tonner E, Allan G, Shkreta L, Webster J, Whitelaw CB, Flint DJ 2000 Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. Adv Exp Med Biol 480:45-53
9. Tonner E, Barber MC, Travers MT, Logan A, Flint DJ 1997 Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology 138:5101-5107
10. Kleinberg DL, Ruan WF, Catanese V, Newman CB, Feldman M 1990 Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-I messenger ribonucleic acid of rat mammary gland. Endocrinology 126:3274-3276
11. Feldman M, Ruan WF, Cunningham BC, Wells JA, Kleinberg DL 1993 Evidence that the growth hormone receptor mediates differentiation and development of the mammary gland. Endocrinology 133:1602-1608
12. Kleinberg DL, Feldman M, Ruan W 2000 IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 5:7-17
13. Ruan W, Catanese V, Wieczorek R, Feldman M, Kleinberg DL 1995 Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid. Endocrinology 136:1296-1302
14. Daniel CW, Silberstein GB 1987 Postnatal development of the rodent mammary gland. In: Neville MC, Daniel CW, eds. The mammary gland. New York: Plenum Press; 3-36
15. Bonnette SG, Hadsell DL 2001 Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142:4937-4945
16. Jackson JG, White MF, Yee D 1998 Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor I, insulin and interleukin-4 in estrogen receptor positive human breast cancer cells. J Biol Chem 273:149-162
17. Hadsell DL, Greenberg NM, Fligger JM, Baumrucker CR, Rosen JM 1996 Targeted expression of des(1-3) human insulin-like growth factor I (IGF-I) in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 136:321-330
18. Hadsell DL, Abdel-Fattah G 2001 Regulation of cell apoptosis by insulin-like growth factor I. Adv Exp Med Biol 501:79-85
19. Tonner E, Barber MC, Allan GJ, Beattie J, Webster J, Whitelaw CB, Flint DJ 2002 Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development 129:4547-4557
20. Guenette RS, Tenniswood M 1994 The role of growth factors in the suppression of active cell death in the prostate: an hypothesis. Biochem Cell Biol 72:553-559
21. Benali N, Ferjoux G, Puente E, Buscail L, Susini C 2000 Somatostatin receptors. Digestion 62(Suppl 1):27-32
22. Isaksson OG, Jansson JO, Gause IA 1982 Growth hormone stimulates longitudinal bone growth directly. Science 216:1237-1239
23. Ruan W, Powell-Braxton L, Kopchick JJ, Kleinberg DL 1999 Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology 140:1984-1989
24. Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G 2002 SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 146:707-716
25. Sharma K, Patel YC, Srikant CB 1996 Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 10:1688-1696
26. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: prospective study. Science 279:563-566
27. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
28. Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni Jr JF, Hsing AW 2001 Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 10:421-427
29. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M 2004 Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353
30. Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FCJ, Alfred DC, Osborne CK 1989 Blockade of the type 1 somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418-1423
31. Yee D, Lee AV 2000 Crosstralk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 5:107-115
32. Huynh H, Yang XF, Pollak M 1996 A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell Growth Differ 7:1501-1506
33. Rozen F, Pollak M 1999 Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: a role for insulinlike growth factor binding proteins. Int J Oncol 15:589-594
34. Nickerson T, Pollak M, Huynh H 1998 Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2,3,4 and 5. Endocrinology 139:807-810
35. Nickerson T, Zhang J, Pollak M 1999 Regression of DMBA-induced breast carcinoma following ovariectomy is associated with increased expression of genes encoding insulin-like growth factor binding proteins. Int J Oncol 14:987-990
36. Allan GJ, Beattie J, Flint DJ 2004 The role of IGFBP-5 in mammary gland development and involution. Domest Anim Endocrinol 27:257-266
37. Weckbecker G, Tolcsvai L, Liu R, Bruns C 1992 Preclinical studies on the anticancer activity of the somatostatin analogue octreotide (SMS 201-995). Metabolism 41:99-103
38. Anderson E, Ferguson JE, Morten H, Shalet SM, Robinson EL, Howell A 1993 Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide. Eur J Cancer 29A:209-217
39. Newman CB, Cosby H, Friesen HG, Feldman M, Cooper P, DeCrescito V, Pilon M, Kleinberg DL 1987 Evidence for a non-prolactin, non-growth hormone mammary mitogen in the human pituitary gland. Proc Natl Acad Sci USA 84:8110-8114
40. Nandi S 1958 Endocrine control of mammary-gland development and function in the C3 11/HE Crgl mouse. J Natl Cancer Inst 21:1039-1062
41. Newman CB, Cosby H, Friesen H, Stampfer MJ, Monaco ME, Kleinberg DL, Novel human pituitary factors stimulate growth of mammary cancer cells and normal mammary gland. 68th Annual Meeting of The Endocrine Society, Anaheim, CA, 1986 (Abstract 15)
42. Walden PD, Ruan WF, Feldman M, Kleinberg DL 1998 Evidence that the mammary gland fat pad mediates the action of growth hormone in mammary gland development. Endocrinology 139:659-662